Table of Content

"1    INTRODUCTION    31
1.1    OBJECTIVES OF THE STUDY    31
1.2    MARKET DEFINITION    31
1.2.1    INCLUSIONS & EXCLUSIONS OF THE STUDY    32
1.3    MARKET SCOPE    33
1.3.1    MARKETS COVERED    33
1.3.2    YEARS CONSIDERED FOR THE STUDY    34
1.4    CURRENCY USED FOR THE STUDY    34
1.5    MAJOR MARKET STAKEHOLDERS    34
1.6    SUMMARY OF CHANGES    35
2    RESEARCH METHODOLOGY    36
2.1    RESEARCH DATA    36
FIGURE 1    RESEARCH DESIGN    36
2.1.1    SECONDARY DATA    37
2.1.1.1    Secondary sources    38
2.1.2    PRIMARY DATA    38
FIGURE 2    BREAKDOWN OF PRIMARIES: INFERTILITY TREATMENT MARKET    39
2.2    MARKET ESTIMATION METHODOLOGY    39
FIGURE 3    RESEARCH METHODOLOGY: HYPOTHESIS BUILDING    40
2.2.1    REVENUE MAPPING-BASED MARKET ESTIMATION    40
2.2.2    USAGE-BASED MARKET ESTIMATION    41
FIGURE 4    MARKET SIZE ESTIMATION: INFERTILITY TREATMENT MARKET
BASED ON PRODUCT UTILIZATION METHODOLOGY    41
FIGURE 5    MARKET SIZE ESTIMATION: INFERTILITY TREATMENT MARKET
BASED ON REVENUE MAPPING METHODOLOGY    42
2.2.3    PRIMARY RESEARCH VALIDATION    42
2.3    DATA TRIANGULATION    43
FIGURE 6    DATA TRIANGULATION METHODOLOGY    43
2.4    RESEARCH ASSUMPTIONS    44
2.5    RESEARCH LIMITATIONS    44
3    EXECUTIVE SUMMARY    45
FIGURE 7    INFERTILITY TREATMENT MARKET, BY PRODUCT,
2021 VS. 2026 (USD MILLION)    45
FIGURE 8    INFERTILITY TREATMENT MARKET, BY PROCEDURE,
2021 VS. 2026 (USD MILLION)    46
FIGURE 9    INFERTILITY TREATMENT MARKET, BY PATIENT TYPE,
2021 VS. 2026 (USD MILLION)    47
FIGURE 10    INFERTILITY TREATMENT MARKET, BY END USER,
2021 VS. 2026 (USD MILLION)    48
FIGURE 11    GEOGRAPHICAL SNAPSHOT OF THE INFERTILITY TREATMENT MARKET    49
4    PREMIUM INSIGHTS    50
4.1    INFERTILITY TREATMENT MARKET OVERVIEW    50
FIGURE 12    DECLINING FERTILITY RATE AND RISING NUMBER OF FERTILITY CLINICS WORLDWIDE TO DRIVE MARKET GROWTH    50
4.2    INFERTILITY TREATMENT MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION)    51
FIGURE 13    MEDIA & CONSUMABLES SEGMENT TO REGISTER THE HIGHEST GROWTH IN THE INFERTILITY TREATMENT MARKET DURING THE FORECAST PERIOD    51
4.3    INFERTILITY TREATMENT MARKET, BY PROCEDURE, 2021 VS. 2026 (USD MILLION)    52
FIGURE 14    ASSISTED REPRODUCTIVE TECHNOLOGY IS THE LARGEST PROCEDURE SEGMENT OF THE INFERTILITY TREATMENT MARKET    52
4.4    INFERTILITY TREATMENT MARKET, BY PATIENT TYPE, 2021 VS. 2026 (USD MILLION)    53
FIGURE 15    MALE INFERTILITY TREATMENT SEGMENT TO WITNESS THE HIGHEST GROWTH IN THE FORECAST PERIOD    53
4.5    INFERTILITY TREATMENT MARKET SHARE, BY END USER, 2021    54
FIGURE 16    FERTILITY CENTERS ARE THE LARGEST END USERS OF INFERTILITY TREATMENT PRODUCTS    54
4.6    ASIA PACIFIC: INFERTILITY TREATMENT MARKET, BY PRODUCT AND COUNTRY (2021)    55
FIGURE 17    EQUIPMENT SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE APAC INFERTILITY TREATMENT MARKET IN 2021    55
FIGURE 18    APAC MARKET TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD (2021–2026)    56
5    MARKET OVERVIEW    57
5.1    INTRODUCTION    57
5.2    MARKET DYNAMICS    57
FIGURE 19    INFERTILITY TREATMENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES    57
5.2.1    DRIVERS    58
5.2.1.1    Declining fertility rate    58
FIGURE 20    DECLINING GLOBAL FERTILITY RATE, BY REGION, 1990 VS. 2019 VS. 2030    58
FIGURE 21    RISING OBESITY RATES (PERCENTAGE OF THE US POPULATION):
2010 VS. 2030    59
5.2.1.2    Rising number of fertility clinics worldwide    60
5.2.1.3    Technological advancements    60
5.2.1.3.1    Advancements in infertility treatment devices    60
5.2.1.3.2    Increasing use of time-lapse technology worldwide    61
5.2.1.4    Increasing public-private investments, funds, and grants    61
5.2.2    RESTRAINTS    62
5.2.2.1    High costs associated with assisted reproductive technology in developed markets    62
TABLE 1    INFERTILITY TREATMENT COSTS    62
5.2.2.2    Unsupportive government regulations    63

5.2.3    OPPORTUNITIES    64
5.2.3.1    Growth opportunities in emerging markets    64
5.2.3.1.1    Improving healthcare infrastructure    64
5.2.3.2    Increasing medical tourism due to low treatment costs    64
5.2.3.3    Use of fertility treatment options by single parents and same-sex couples    65
5.2.4    CHALLENGES    65
5.2.4.1    Concerns related to ART procedures    65
5.2.4.2    Reduced efficacy among older women    66
5.3    REGULATORY LANDSCAPE    66
5.3.1    NORTH AMERICA    66
5.3.1.1    US    66
5.3.1.2    Canada    67
5.3.2    EUROPE    67
5.3.3    ASIA PACIFIC    67
5.3.3.1    India    67
5.3.3.2    Japan    67
TABLE 2    JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA    68
5.4    COVID-19 IMPACT ON THE INFERTILITY TREATMENT MARKET    68
5.5    VALUE CHAIN ANALYSIS    69
FIGURE 22    VALUE CHAIN OF THE INFERTILITY TREATMENT MARKET    69
5.6    PRICING TREND ANALYSIS    70
TABLE 3    AVERAGE PRICE OF INFERTILITY TREATMENT EQUIPMENT AND MEDIA,
BY COUNTRY, 2020 (USD)    70
5.7    PORTER’S FIVE FORCES ANALYSIS    71
TABLE 4    INFERTILITY TREATMENT MARKET: PORTER’S FIVE FORCES ANALYSIS    71
5.7.1    THREAT OF NEW ENTRANTS    71
FIGURE 23    THREAT OF NEW ENTRANTS    72
5.7.2    THREAT OF SUBSTITUTES    72
FIGURE 24    THREAT OF SUBSTITUTES    72
5.7.3    BARGAINING POWER OF SUPPLIERS    73
FIGURE 25    BARGAINING POWER OF SUPPLIERS    73
5.7.4    BARGAINING POWER OF BUYERS    73
FIGURE 26    BARGAINING POWER OF BUYERS    73
5.7.5    INTENSITY OF COMPETITIVE RIVALRY    74
FIGURE 27    INTENSITY OF COMPETITIVE RIVALRY    74
5.8    ECOSYSTEM COVERAGE    74

6    INFERTILITY TREATMENT MARKET, BY PRODUCT    75
6.1    INTRODUCTION    76
TABLE 5    INFERTILITY TREATMENT MARKET, BY PRODUCT, 2019–2026 (USD MILLION)    76
6.1.1    EQUIPMENT    76
TABLE 6    INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION)    77
TABLE 7    INFERTILITY TREATMENT EQUIPMENT MARKET, BY REGION,
2019–2026 (USD MILLION)    77
6.2    MICROSCOPES    78
6.2.1    TECHNOLOGICAL ADVANCEMENTS IN THE FIELD OF MICROSCOPY HAS RESULTED IN THE GROWING ADOPTION OF MICROSCOPES    78
TABLE 8    MICROSCOPES MARKET, BY REGION, 2019–2026 (USD MILLION)    78
TABLE 9    MICROSCOPES MARKET, BY PROCEDURE, 2019–2026 (USD MILLION)    79
TABLE 10    MICROSCOPES MARKET, BY PATIENT TYPE, 2019–2026 (USD MILLION)    79
TABLE 11    MICROSCOPES MARKET, BY END USER, 2019–2026 (USD MILLION)    80
6.2.2    IMAGING SYSTEMS    80
6.2.2.1    Advantages offered by imaging systems in the field of infertility treatment are driving their adoption    80
TABLE 12    IMAGING SYSTEMS MARKET, BY REGION, 2019–2026 (USD MILLION)    81
TABLE 13    IMAGING SYSTEMS MARKET, BY PROCEDURE, 2019–2026 (USD MILLION)    81
TABLE 14    IMAGING SYSTEMS MARKET, BY PATIENT TYPE, 2019–2026 (USD MILLION)    82
TABLE 15    IMAGING SYSTEMS MARKET, BY END USER, 2019–2026 (USD MILLION)    82
6.2.3    SPERM ANALYZER SYSTEMS    82
6.2.3.1    Sperm analyzer systems have a wide range of applications in fertility screening    82
TABLE 16    SPERM ANALYZER SYSTEMS MARKET, BY REGION,
2019–2026 (USD MILLION)    83
TABLE 17    SPERM ANALYZER SYSTEMS MARKET, BY PROCEDURE,
2019–2026 (USD MILLION)    83
TABLE 18    SPERM ANALYZER SYSTEMS MARKET, BY PATIENT TYPE,
2019–2026 (USD MILLION)    84
TABLE 19    SPERM ANALYZER SYSTEMS MARKET, BY END USER,
2019–2026 (USD MILLION)    84
6.2.4    OVUM ASPIRATION PUMPS    84
6.2.4.1    Ovum aspiration pumps are widely used to retrieve and protect oocytes    84
TABLE 20    OVUM ASPIRATION PUMPS MARKET, BY REGION,
2019–2026 (USD MILLION)    85
TABLE 21    OVUM ASPIRATION PUMPS MARKET, BY PROCEDURE,
2019–2026 (USD MILLION)    85
TABLE 22    OVUM ASPIRATION PUMPS MARKET, BY PATIENT TYPE,
2019–2026 (USD MILLION)    86
TABLE 23    OVUM ASPIRATION PUMPS MARKET, BY END USER,
2019–2026 (USD MILLION)    86
6.2.5    MICROMANIPULATOR SYSTEMS    86
6.2.5.1    Micromanipulator systems are used in cases pertaining to poor sperm quality/mobility    86
TABLE 24    MICROMANIPULATOR SYSTEMS MARKET, BY REGION,
2019–2026 (USD MILLION)    87
TABLE 25    MICROMANIPULATOR SYSTEMS MARKET, BY PROCEDURE,
2019–2026 (USD MILLION)    88
TABLE 26    MICROMANIPULATOR SYSTEMS MARKET, BY PATIENT TYPE,
2019–2026 (USD MILLION)    88
TABLE 27    MICROMANIPULATOR SYSTEMS MARKET, BY END USER,
2019–2026 (USD MILLION)    89
6.2.6    INCUBATORS    89
6.2.6.1    Incubators play a vital role in embryo development and improved clinical outcomes    89
TABLE 28    INCUBATORS MARKET, BY REGION, 2019–2026 (USD MILLION)    90
TABLE 29    INCUBATORS MARKET, BY PROCEDURE, 2019–2026 (USD MILLION)    90
TABLE 30    INCUBATORS MARKET, BY PATIENT TYPE, 2019–2026 (USD MILLION)    91
TABLE 31    INCUBATORS MARKET, BY END USER, 2019–2026 (USD MILLION)    91
6.2.7    GAS ANALYZERS    91
6.2.7.1    Gas analyzers contain multiple ports enabling analysis of sequential gas samples    91
TABLE 32    GAS ANALYZERS MARKET, BY REGION, 2019–2026 (USD MILLION)    92
TABLE 33    GAS ANALYZERS MARKET, BY PROCEDURE, 2019–2026 (USD MILLION)    92
TABLE 34    GAS ANALYZERS MARKET, BY PATIENT TYPE, 2019–2026 (USD MILLION)    93
TABLE 35    GAS ANALYZERS MARKET, BY END USER, 2019–2026 (USD MILLION)    93
6.2.8    LASER SYSTEMS    93
6.2.8.1    Common applications of laser systems include the treatment of stress urinary incontinence and vaginal tightening    93
TABLE 36    LASER SYSTEMS MARKET, BY REGION, 2019–2026 (USD MILLION)    94
TABLE 37    LASER SYSTEMS MARKET, BY PROCEDURE, 2019–2026 (USD MILLION)    94
TABLE 38    LASER SYSTEMS MARKET, BY PATIENT TYPE, 2019–2026 (USD MILLION)    95
TABLE 39    LASER SYSTEMS MARKET, BY END USER, 2019–2026 (USD MILLION)    95
6.2.9    CRYOSYSTEMS    95
6.2.9.1    Demand for cryosystems is on the rise as women are seeking to extend their childbearing years    95
TABLE 40    CRYOSYSTEMS MARKET, BY REGION, 2019–2026 (USD MILLION)    96
TABLE 41    CRYOSYSTEMS MARKET, BY PROCEDURE, 2019–2026 (USD MILLION)    96
TABLE 42    CRYOSYSTEMS MARKET, BY PATIENT TYPE, 2019–2026 (USD MILLION)    97
TABLE 43    CRYOSYSTEMS MARKET, BY END USER, 2019–2026 (USD MILLION)    97
6.2.10    SPERM SEPARATION DEVICES    98
6.2.10.1    Introduction of advanced sperm separation devices to boost their adoption    98
TABLE 44    SPERM SEPARATION DEVICES MARKET, BY REGION,
2019–2026 (USD MILLION)    98
TABLE 45    SPERM SEPARATION DEVICES MARKET, BY PROCEDURE,
2019–2026 (USD MILLION)    99
TABLE 46    SPERM SEPARATION DEVICES MARKET, BY PATIENT TYPE,
2019–2026 (USD MILLION)    99
TABLE 47    SPERM SEPARATION DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION)    100
6.3    MEDIA & CONSUMABLES    100
6.3.1    EASY AVAILABILITY OF CULTURE MEDIA TO SUPPORT MARKET GROWTH    100
TABLE 48    INFERTILITY TREATMENT MEDIA & CONSUMABLES MARKET, BY REGION, 2019–2026 (USD MILLION)    101
TABLE 49    INFERTILITY TREATMENT MEDIA & CONSUMABLES MARKET, BY PROCEDURE, 2019–2026 (USD MILLION)    101
TABLE 50    INFERTILITY TREATMENT MEDIA & CONSUMABLES MARKET, BY PATIENT TYPE, 2019–2026 (USD MILLION)    102
TABLE 51    INFERTILITY TREATMENT MEDIA & CONSUMABLES MARKET, BY END USER, 2019–2026 (USD MILLION)    102
6.4    ACCESSORIES    103
6.4.1    ANTI-VIBRATION TABLES ARE COMMONLY USED FOR IVF TREATMENTS TO PROVIDE A SMOOTH WORKSPACE DURING PROCEDURES    103
TABLE 52    INFERTILITY TREATMENT ACCESSORIES MARKET, BY REGION,
2019–2026 (USD MILLION)    103
TABLE 53    INFERTILITY TREATMENT ACCESSORIES MARKET, BY PROCEDURE,
2019–2026 (USD MILLION)    104
TABLE 54    INFERTILITY TREATMENT ACCESSORIES MARKET, BY PATIENT TYPE,
2019–2026 (USD MILLION)    104
TABLE 55    INFERTILITY TREATMENT ACCESSORIES MARKET, BY END USER,
2019–2026 (USD MILLION)    105
7    INFERTILITY TREATMENT MARKET, BY PROCEDURE    106
7.1    INTRODUCTION    107
TABLE 56    INFERTILITY TREATMENT MARKET, BY PROCEDURE,
2019–2026 (USD MILLION)    107
7.2    ASSISTED REPRODUCTIVE TECHNOLOGY    107
TABLE 57    ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY TYPE,
2019–2026 (USD MILLION)    108
TABLE 58    ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY REGION,
2019–2026 (USD MILLION)    108
7.2.1    IN VITRO FERTILIZATION    108
FIGURE 28    UK: IVF BIRTH RATES, 2010–2019    109
TABLE 59    IN VITRO FERTILIZATION MARKET, BY TYPE, 2019–2026 (USD MILLION)    109
TABLE 60    IN VITRO FERTILIZATION MARKET, BY REGION, 2019–2026 (USD MILLION)    110
7.2.1.1    Intracytoplasmic morphologically selected sperm injection    110
7.2.1.1.1    IMSI is highly recommended in patients with a low sperm count and recurrent implantation failure    110
TABLE 61    INTRACYTOPLASMIC MORPHOLOGICALLY SELECTED SPERM INJECTION MARKET, BY REGION, 2019–2026 (USD MILLION)    111
7.2.1.2    Gamete donation    111
7.2.1.2.1    Increasing number of women registering as egg donors is a key factor aiding market growth    111
TABLE 62    GAMETE DONATION MARKET, BY REGION, 2019–2026 (USD MILLION)    112
7.2.2    INTRACYTOPLASMIC SPERM INJECTION    112
7.2.2.1    ICSI is a specialized form of IVF involving fertilization used commonly in male infertility treatment procedures    112
TABLE 63    INTRACYTOPLASMIC SPERM INJECTION MARKET, BY REGION,
2019–2026 (USD MILLION)    113
7.2.3    SURROGACY    113
7.2.3.1    High success rates guaranteed and achieved with the help of surrogacy are driving market growth    113
TABLE 64    SURROGACY MARKET, BY REGION, 2019–2026 (USD MILLION)    114
7.3    ARTIFICIAL INSEMINATION    114
TABLE 65    ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2019–2026 (USD MILLION)    115
TABLE 66    ARTIFICIAL INSEMINATION MARKET, BY REGION, 2019–2026 (USD MILLION)    115
7.3.1    INTRAUTERINE INSEMINATION    116
7.3.1.1    Limited risk of complications during pregnancy and high success rate are driving the market for IUI procedures    116
TABLE 67    INTRAUTERINE INSEMINATION MARKET, BY REGION,
2019–2026 (USD MILLION)    116
7.3.2    INTRACERVICAL INSEMINATION    117
7.3.2.1    Low cost of this procedure as compared to other AI procedures to support market growth    117
TABLE 68    INTRACERVICAL INSEMINATION MARKET, BY REGION,
2019–2026 (USD MILLION)    117
7.3.3    INTRATUBAL INSEMINATION    117
7.3.3.1    High cost and uncertain success rate of this procedure to restrain the market growth    117
TABLE 69    INTRATUBAL INSEMINATION MARKET, BY REGION,
2019–2026 (USD MILLION)    118
7.4    FERTILITY SURGERIES    118
TABLE 70    FERTILITY SURGERIES MARKET, BY TYPE, 2019–2026 (USD MILLION)    118
TABLE 71    FERTILITY SURGERIES MARKET, BY REGION, 2019–2026 (USD MILLION)    119
7.4.1    LAPAROSCOPY    119
7.4.1.1    Laparoscopy allows for the biopsy of suspect growths and cysts that hamper fertility    119
TABLE 72    LAPAROSCOPY MARKET, BY REGION, 2019–2026 (USD MILLION)    120
7.4.2    HYSTEROSCOPY    120
7.4.2.1    Growing demand for minimally invasive procedures is driving the adoption of hysteroscopy infertility treatment surgeries globally    120
TABLE 73    HYSTEROSCOPY MARKET, BY REGION, 2019–2026 (USD MILLION)    121
7.4.3    MYOMECTOMY    121
7.4.3.1    Advantages of myomectomy in alleviating problems caused due to fibroids while preserving future fertility to drive the demand for this surgery    121
TABLE 74    MYOMECTOMY MARKET, BY REGION, 2019–2026 (USD MILLION)    122
7.4.4    LAPAROTOMY    122
7.4.4.1    Laparotomy is used in common infertility surgeries that require large exposure to the reproductive system    122
TABLE 75    LAPAROTOMY MARKET, BY REGION, 2019–2026 (USD MILLION)    122
7.4.5    TUBAL LIGATION REVERSAL    123
7.4.5.1    Tubal ligation reversal is performed in women who still have a large portion of healthy fallopian tube remaining    123
TABLE 76    TUBAL LIGATION REVERSAL MARKET, BY REGION,
2019–2026 (USD MILLION)    123
7.4.6    VARICOCELECTOMY    124
7.4.6.1    Varicocelectomy results in a high chance of improved fertility with reduced complications    124
TABLE 77    VARICOCELECTOMY MARKET, BY REGION, 2019–2026 (USD MILLION)    124
7.4.7    MICROSURGICAL RECONSTRUCTION    124
TABLE 78    MICROSURGICAL RECONSTRUCTION MARKET, BY TYPE,
2019–2026 (USD MILLION)    125
TABLE 79    MICROSURGICAL RECONSTRUCTION MARKET, BY REGION,
2019–2026 (USD MILLION)    125
7.4.7.1    Vasovasostomy    125
7.4.7.1.1    Vasovasostomy is a reversal surgery commonly used in the treatment of infertility in men    125
TABLE 80    VASOVASOSTOMY MARKET, BY REGION, 2019–2026 (USD MILLION)    126
7.4.7.2    Vasoepididymostomy    126
7.4.7.2.1    Vasoepididymostomy provides a higher pregnancy rate than IVF with ICSI    126
TABLE 81    VASOEPIDIDYMOSTOMY MARKET, BY REGION, 2019–2026 (USD MILLION)    127
7.5    OTHER INFERTILITY TREATMENT PROCEDURES    127
TABLE 82    OTHER INFERTILITY TREATMENT PROCEDURES MARKET, BY REGION,
2019–2026 (USD MILLION)    128
8    INFERTILITY TREATMENT MARKET, BY PATIENT TYPE    129
8.1    INTRODUCTION    130
TABLE 83    INFERTILITY TREATMENT MARKET, BY PATIENT TYPE,
 2019–2026 (USD MILLION)    130
8.2    FEMALE INFERTILITY TREATMENT    130
8.2.1    INCREASING FEMALE INFERTILITY RATES TO DRIVE THE GROWTH OF THE FEMALE INFERTILITY TREATMENT MARKET    130
FIGURE 29    US: IVF SUCCESS RATES BY AGE FOR ALL IVF CYCLES, 2019    131
TABLE 84    FEMALE INFERTILITY TREATMENT MARKET, BY REGION,
2019–2026 (USD MILLION)    131
8.3    MALE INFERTILITY TREATMENT    132
8.3.1    GROWING ADOPTION OF MALE INFERTILITY TREATMENT PROCEDURES TO DRIVE MARKET GROWTH    132
TABLE 85    MALE INFERTILITY TREATMENT MARKET, BY REGION,
2019–2026 (USD MILLION)    132

9    INFERTILITY TREATMENT MARKET, BY END USER    133
9.1    INTRODUCTION    134
TABLE 86    INFERTILITY TREATMENT MARKET, BY END USER, 2019–2026 (USD MILLION)    134
9.2    FERTILITY CENTERS    134
9.2.1    GROWING NUMBER OF INFERTILITY TREATMENT CENTERS WORLDWIDE TO DRIVE MARKET GROWTH    134
TABLE 87    INFERTILITY TREATMENT MARKET FOR FERTILITY CENTERS, BY REGION, 2019–2026 (USD MILLION)    135
9.3    HOSPITALS & SURGICAL CLINICS    135
9.3.1    GOVERNMENT INITIATIVES TO INCREASE HOSPITALS EQUIPPED TO PERFORM INFERTILITY TREATMENT PROCEDURES IS SUPPORTING MARKET GROWTH    135
TABLE 88    INFERTILITY TREATMENT MARKET FOR HOSPITALS & SURGICAL CLINICS, BY REGION, 2019–2026 (USD MILLION)    136
9.4    CRYOBANKS    136
9.4.1    INCREASING NUMBER OF ART PROCEDURES USING DONOR SPERM AND DONOR EGGS FOR INFERTILITY TREATMENT TO DRIVE MARKET GROWTH    136
TABLE 89    INFERTILITY TREATMENT MARKET FOR CRYOBANKS, BY REGION,
2019–2026 (USD MILLION)    137
9.5    RESEARCH INSTITUTES    137
9.5.1    GROWING NEED FOR IMPROVING THE CLINICAL EFFICACY OF VARIOUS INFERTILITY TREATMENT OPTIONS TO DRIVE MARKET GROWTH    137
TABLE 90    INFERTILITY TREATMENT MARKET FOR RESEARCH INSTITUTES, BY REGION, 2019–2026 (USD MILLION)    138
10    INFERTILITY TREATMENT MARKET, BY REGION    139
10.1    INTRODUCTION    140
TABLE 91    INFERTILITY TREATMENT MARKET, BY REGION, 2019–2026 (USD MILLION)    140
10.2    ASIA PACIFIC    140
TABLE 93    ASIA PACIFIC: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION)    142
TABLE 94    ASIA PACIFIC: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION)    142
TABLE 95    ASIA PACIFIC: INFERTILITY TREATMENT MARKET, BY PROCEDURE,
2019–2026 (USD MILLION)    143
TABLE 96    ASIA PACIFIC: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY TYPE, 2019–2026 (USD MILLION)    143
TABLE 97    ASIA PACIFIC: IN VITRO FERTILIZATION MARKET, BY TYPE,
2019–2026 (USD MILLION)    144
TABLE 98    ASIA PACIFIC: ARTIFICIAL INSEMINATION MARKET, BY TYPE,
 2019–2026 (USD MILLION)    144
TABLE 99    ASIA PACIFIC: FERTILITY SURGERIES MARKET, BY TYPE,
2019–2026 (USD MILLION)    145
TABLE 100    ASIA PACIFIC: MICROSURGICAL RECONSTRUCTION MARKET, BY TYPE, 2019–2026 (USD MILLION)    145
TABLE 101    ASIA PACIFIC: INFERTILITY TREATMENT MARKET, BY PATIENT TYPE,
2019–2026 (USD MILLION)    146
TABLE 102    ASIA PACIFIC: INFERTILITY TREATMENT MARKET, BY END USER,
2019–2026 (USD MILLION)    146
10.2.1    CHINA    147
10.2.1.1    Declining birth rate in China to drive the demand for infertility treatment procedures in the country    147
TABLE 103    CHINA: INFERTILITY TREATMENT MARKET, BY PRODUCT,
 2019–2026 (USD MILLION)    147
TABLE 104    CHINA: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION)    148
10.2.2    JAPAN    148
10.2.2.1    Growing awareness has served to boost the adoption of IVF procedures in Japan    148
TABLE 105    JAPAN: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION)    149
TABLE 106    JAPAN: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION)    150
10.2.3    INDIA    150
10.2.3.1    Rising medical tourism to offer high-growth opportunities for players in the Indian infertility treatment market    150
TABLE 107    INDIA: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION)    151
TABLE 108    INDIA: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION)    152
10.2.4    AUSTRALIA    152
10.2.4.1    Initiatives by the Australian government to support market growth    152
TABLE 109    AUSTRALIA: INFERTILITY TREATMENT MARKET, BY PRODUCT,
 2019–2026 (USD MILLION)    153
TABLE 110    AUSTRALIA: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION)    153
10.2.5    SOUTH KOREA    154
10.2.5.1    Supportive government initiatives will positively impact market growth    154
TABLE 111    SOUTH KOREA: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION)    154
TABLE 112    SOUTH KOREA: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)    155
10.2.6    REST OF ASIA PACIFIC    155
TABLE 113    ROAPAC: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION)    156
TABLE 114    ROAPAC: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION)    156
10.3    EUROPE    157
TABLE 115    EUROPE: INFERTILITY TREATMENT MARKET, BY COUNTRY,
 2019–2026 (USD MILLION)    157
TABLE 116    EUROPE: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION)    158
TABLE 117    EUROPE: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE,
 2019–2026 (USD MILLION)    158
TABLE 118    EUROPE: INFERTILITY TREATMENT MARKET, BY PROCEDURE,
2019–2026 (USD MILLION)    159
TABLE 119    EUROPE: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY TYPE,
2019–2026 (USD MILLION)    159
TABLE 120    EUROPE: IN VITRO FERTILIZATION MARKET, BY TYPE,
2019–2026 (USD MILLION)    160
TABLE 121    EUROPE: ARTIFICIAL INSEMINATION MARKET, BY TYPE,
2019–2026 (USD MILLION)    160
TABLE 122    EUROPE: FERTILITY SURGERIES MARKET, BY TYPE,
2019–2026 (USD MILLION)    161
TABLE 123    EUROPE: MICROSURGICAL RECONSTRUCTION MARKET, BY TYPE,
2019–2026 (USD MILLION)    161
TABLE 124    EUROPE: INFERTILITY TREATMENT MARKET, BY PATIENT TYPE,
2019–2026 (USD MILLION)    162
TABLE 125    EUROPE: INFERTILITY TREATMENT MARKET, BY END USER,
2019–2026 (USD MILLION)    162
10.3.1    GERMANY    162
10.3.1.1    Favorable funding scenario for IVF treatments in Germany to drive market growth    162
TABLE 126    GERMANY: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION)    163
TABLE 127    GERMANY: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION)    164
10.3.2    UK    164
10.3.2.1    Supportive regulatory framework in the UK to drive market growth    164
FIGURE 31    UK: NUMBER OF IVF CYCLES BY EGG AND SPERM SOURCE, 2010-2019    165
TABLE 128    UK: INFERTILITY TREATMENT MARKET, BY PRODUCT,
 2019–2026 (USD MILLION)    165
TABLE 129    UK: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION)    166
10.3.3    FRANCE    166
10.3.3.1    Rising healthcare spending in France to drive market growth    166
TABLE 130    FRANCE: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION)    167
TABLE 131    FRANCE: INFERTILITY TREATMENT EQUIPMENT MARKET,
 BY TYPE, 2019–2026 (USD MILLION)    168
10.3.4    ITALY    168
10.3.4.1    Decreasing fertility rates to drive the demand for fertility testing treatment procedures in Italy    168
TABLE 132    ITALY: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION)    169
TABLE 133    ITALY: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION)    169
10.3.5    SPAIN    170
10.3.5.1    Spain is an established destination for IVF tourism    170
TABLE 134    SPAIN: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION)    170
TABLE 135    SPAIN: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION)    171
10.3.6    REST OF EUROPE    171
TABLE 136    ROE: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION)    172
TABLE 137    ROE: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION)    172
10.4    NORTH AMERICA    173
TABLE 138    NORTH AMERICA: INFERTILITY TREATMENT MARKET, BY COUNTRY,
2019–2026 (USD MILLION)    173
TABLE 139    NORTH AMERICA: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION)    173
TABLE 140    NORTH AMERICA: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)    174
TABLE 141    NORTH AMERICA: INFERTILITY TREATMENT MARKET, BY PROCEDURE,
2019–2026 (USD MILLION)    174
TABLE 142    NORTH AMERICA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY TYPE, 2019–2026 (USD MILLION)    175
TABLE 143    NORTH AMERICA: IN VITRO FERTILIZATION MARKET, BY TYPE,
2019–2026 (USD MILLION)    175
TABLE 144    NORTH AMERICA: ARTIFICIAL INSEMINATION MARKET, BY TYPE,
2019–2026 (USD MILLION)    176
TABLE 145    NORTH AMERICA: FERTILITY SURGERIES MARKET, BY TYPE,
2019–2026 (USD MILLION)    176
TABLE 146    NORTH AMERICA: MICROSURGICAL RECONSTRUCTION MARKET, BY TYPE, 2019–2026 (USD MILLION)    177
TABLE 147    NORTH AMERICA: INFERTILITY TREATMENT MARKET, BY PATIENT TYPE,
2019–2026 (USD MILLION)    177
TABLE 148    NORTH AMERICA: INFERTILITY TREATMENT MARKET, BY END USER,
2019–2026 (USD MILLION)    178
10.4.1    US    178
10.4.1.1    The US dominates the infertility treatment market in North America    178
TABLE 149    US: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION)    179
TABLE 150    US: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION)    180
10.4.2    CANADA    180
10.4.2.1    High cost of infertility treatment in the country to restrain the market growth    180
TABLE 151    CANADA: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION)    181
TABLE 152    CANADA: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION)    181
10.5    LATIN AMERICA    182
TABLE 153    LATIN AMERICA: INFERTILITY TREATMENT MARKET, BY COUNTRY,
2019–2026 (USD MILLION)    182
TABLE 154    LATIN AMERICA: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION)    182
TABLE 155    LATIN AMERICA: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)    183
TABLE 156    LATIN AMERICA: INFERTILITY TREATMENT MARKET, BY PROCEDURE,
2019–2026 (USD MILLION)    183
TABLE 157    LATIN AMERICA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY TYPE, 2019–2026 (USD MILLION)    184
TABLE 158    LATIN AMERICA: IN VITRO FERTILIZATION MARKET, BY TYPE,
 2019–2026 (USD MILLION)    184
TABLE 159    LATIN AMERICA: ARTIFICIAL INSEMINATION MARKET, BY TYPE,
2019–2026 (USD MILLION)    185
TABLE 160    LATIN AMERICA: FERTILITY SURGERIES MARKET, BY TYPE,
2019–2026 (USD MILLION)    185
TABLE 161    LATIN AMERICA: MICROSURGICAL RECONSTRUCTION MARKET, BY TYPE, 2019–2026 (USD MILLION)    186
TABLE 162    LATIN AMERICA: INFERTILITY TREATMENT MARKET, BY PATIENT TYPE,
2019–2026 (USD MILLION)    186
TABLE 163    LATIN AMERICA: INFERTILITY TREATMENT MARKET, BY END USER,
2019–2026 (USD MILLION)    187
10.5.1    BRAZIL    187
10.5.1.1    Brazil holds the largest share of the Latin American infertility treatment market    187
TABLE 164    BRAZIL: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION)    187
TABLE 165    BRAZIL: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION)    188
10.5.2    MEXICO    188
10.5.2.1    Growth in medical tourism is a key factor driving market growth    188
TABLE 166    MEXICO: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION)    189
TABLE 167    MEXICO: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION)    189
10.5.3    REST OF LATIN AMERICA    190
TABLE 168    ROLATAM: INFERTILITY TREATMENT MARKET, BY PRODUCT,
2019–2026 (USD MILLION)    190
TABLE 169    ROLATAM: INFERTILITY TREATMENT EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION)    191
10.6    MIDDLE EAST & AFRICA    191
10.6.1    RISING INCIDENCE OF INFERTILITY TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD    191
TABLE 170    MIDDLE EAST & AFRICA: INFERTILITY TREATMENT MARKET, BY PRODUCT, 2019–2026 (USD MILLION)    192
TABLE 171    MIDDLE EAST & AFRICA: INFERTILITY TREATMENT EQUIPMENT MARKET,
BY TYPE, 2019–2026 (USD MILLION)    193
TABLE 172    MIDDLE EAST & AFRICA: INFERTILITY TREATMENT MARKET, BY PROCEDURE, 2019–2026 (USD MILLION)    193
TABLE 173    MIDDLE EAST & AFRICA: ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, BY TYPE, 2019–2026 (USD MILLION)    194
TABLE 174    MIDDLE EAST & AFRICA: IN VITRO FERTILIZATION MARKET, BY TYPE,
2019–2026 (USD MILLION)    194
TABLE 175    MIDDLE EAST & AFRICA: ARTIFICIAL INSEMINATION MARKET, BY TYPE, 2019–2026 (USD MILLION)    195
TABLE 176    MIDDLE EAST & AFRICA: FERTILITY SURGERIES MARKET, BY TYPE,
2019–2026 (USD MILLION)    195
TABLE 177    MIDDLE EAST & AFRICA: MICROSURGICAL RECONSTRUCTION MARKET,
BY TYPE, 2019–2026 (USD MILLION)    196
TABLE 178    MIDDLE EAST & AFRICA: INFERTILITY TREATMENT MARKET, BY PATIENT TYPE, 2019–2026 (USD MILLION)    196
TABLE 179    MIDDLE EAST & AFRICA: INFERTILITY TREATMENT MARKET, BY END USER, 2019–2026 (USD MILLION)    197
11    COMPETITIVE LANDSCAPE    198
11.1    OVERVIEW    198
11.2    KEY PLAYER STRATEGIES    198
11.3    REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS    199
FIGURE 32    REVENUE SHARE ANALYSIS OF THE TOP PLAYERS IN THE INFERTILITY TREATMENT MARKET    199
11.4    MARKET SHARE ANALYSIS (2020)    199
TABLE 180    INFERTILITY TREATMENT MARKET: DEGREE OF COMPETITION    199
11.5    COMPETITIVE LEADERSHIP MAPPING    201
11.5.1    STARS    201
11.5.2    PERVASIVE PLAYERS    201
11.5.3    EMERGING LEADERS    201
11.5.4    PARTICIPANTS    202
FIGURE 33    INFERTILITY TREATMENT MARKET: COMPETITIVE LEADERSHIP
MAPPING, 2020    202
11.6    COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES (2020)    203
11.6.1    PROGRESSIVE COMPANIES    203
11.6.2    STARTING BLOCKS    203
11.6.3    RESPONSIVE COMPANIES    203
11.6.4    DYNAMIC COMPANIES    203
FIGURE 34    INFERTILITY TREATMENT MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES, 2020    204
11.7    FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE INFERTILITY TREATMENT MARKET    205
11.7.1    PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE INFERTILITY TREATMENT MARKET    205
TABLE 181    PRODUCT FOOTPRINT OF COMPANIES    206
11.8    COMPETITIVE SCENARIO    208
11.8.1    INFERTILITY TREATMENT MARKET: PRODUCT LAUNCHES AND
REGULATORY APPROVALS    208
TABLE 183    KEY PRODUCT LAUNCHES AND REGULATORY APPROVALS, JANUARY
2018–SEPTEMBER 2021    208
11.8.2    INFERTILITY TREATMENT MARKET: DEALS    208
TABLE 184    KEY DEALS, JANUARY 2018–SEPTEMBER 2021    208
11.8.3    INFERTILITY TREATMENT MARKET: OTHER DEVELOPMENTS    209
TABLE 185    OTHER KEY DEVELOPMENTS, JANUARY 2018–SEPTEMBER 2021    209
12    COMPANY PROFILES    210
12.1    MAJOR PLAYERS    210
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1    THE COOPER COMPANIES INC.    210
TABLE 186    THE COOPER COMPANIES INC.: BUSINESS OVERVIEW    210
FIGURE 35    THE COOPER COMPANIES INC.: COMPANY SNAPSHOT (2020)    211
TABLE 187    THE COOPER COMPANIES, INC.: PRODUCT OFFERINGS    212
12.1.2    COOK GROUP    214
TABLE 188    COOK GROUP: BUSINESS OVERVIEW    214
TABLE 189    COOK GROUP: PRODUCT OFFERINGS    214
12.1.3    VITROLIFE    216
TABLE 190    VITROLIFE: BUSINESS OVERVIEW    216
FIGURE 36    VITROLIFE: COMPANY SNAPSHOT (2020)    217
TABLE 191    VITROLIFE: PRODUCT OFFERINGS    218
12.1.4    THERMO FISHER SCIENTIFIC    220
TABLE 192    THERMO FISHER SCIENTIFIC: BUSINESS OVERVIEW    220
FIGURE 37    THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2020)    221
TABLE 193    THERMO FISHER SCIENTIFIC: PRODUCT OFFERINGS    222
12.1.5    HAMILTON THORNE LTD.    224
TABLE 194    HAMILTON THORNE LTD.: BUSINESS OVERVIEW    224
FIGURE 38    HAMILTON THORNE LTD.: COMPANY SNAPSHOT (2020)    224
TABLE 195    HAMILTON THORNE LTD.: PRODUCT OFFERINGS    225
12.1.6    ESCO MICRO PTE. LTD.    227
TABLE 196    ESCO MICRO PTE. LTD.: BUSINESS OVERVIEW    227
TABLE 197    ESCO MICRO PTE. LTD.: PRODUCT OFFERINGS    227
12.1.7    GENEA LIMITED    229
TABLE 198    GENEA LIMITED: BUSINESS OVERVIEW    229
TABLE 199    GENEA LIMITED: PRODUCT OFFERINGS    229
12.1.8    IVFTECH APS    231
TABLE 200    IVFTECH APS: BUSINESS OVERVIEW    231
TABLE 201    IVFTECH APS: PRODUCT OFFERINGS    231
12.1.9    FUJIFILM IRVINE SCIENTIFIC    232
TABLE 202    FUJIFILM IRVINE SCIENTIFIC: BUSINESS OVERVIEW    232
FIGURE 39    FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT (2020)    232
TABLE 203    FUJIFILM IRVINE SCIENTIFIC: PRODUCT OFFERINGS    233
12.1.10    THE BAKER COMPANY, INC.    235
TABLE 204    THE BAKER COMPANY, INC.: BUSINESS OVERVIEW    235
TABLE 205    THE BAKER COMPANY, INC.: PRODUCT OFFERINGS    235
12.1.11    KITAZATO CORPORATION    236
TABLE 206    KITAZATO CORPORATION: BUSINESS OVERVIEW    236
TABLE 207    KITAZATO CORPORATION: PRODUCT OFFERINGS    236
12.1.12    ROCKET MEDICAL PLC    238
TABLE 208    ROCKET MEDICAL PLC: BUSINESS OVERVIEW    238
TABLE 209    ROCKET MEDICAL PLC: PRODUCT OFFERINGS    238
12.1.13    IHMEDICAL A/S    239
TABLE 210    IHMEDICAL A/S: BUSINESS OVERVIEW    239
TABLE 211    IHMEDICAL A/S: PRODUCT OFFERINGS    239
12.1.14    ZEISS GROUP    240
TABLE 212    ZEISS GROUP: BUSINESS OVERVIEW    240
FIGURE 40    ZEISS GROUP: COMPANY SNAPSHOT (2020)    241
TABLE 213    ZEISS GROUP: PRODUCT OFFERINGS    241
12.1.15    MEDGYN PRODUCTS, INC.    242
TABLE 214    MEDGYN PRODUCTS, INC.: BUSINESS OVERVIEW    242
TABLE 215    MEDGYN PRODUCTS, INC.: PRODUCT OFFERINGS    242
12.2    OTHER PLAYERS    234
12.2.1    DXNOW, INC.    234
12.2.2    NIDACON INTERNATIONAL AB    235
12.2.3    GYNOTEC B.V.    235
12.2.4    SAR HEALTHLINE PVT. LTD.    236
12.2.5    INVITROCARE INC.    237
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13    APPENDIX    247
13.1    DISCUSSION GUIDE    247
13.2    KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL    251
13.3    AVAILABLE CUSTOMIZATIONS    253
13.4    RELATED REPORTS    254
13.5    AUTHOR DETAILS    255"